M. Mirabella et al., DIFFERENCE IN EXPRESSION OF PHOSPHORYLATED TAU-EPITOPE BETWEEN SPORADIC INCLUSION-BODY MYOSITIS AND HEREDITARY INCLUSION-BODY MYOPATHIES, Journal of neuropathology and experimental neurology, 55(7), 1996, pp. 774-786
Sporadic inclusion-body myositis (s-IBM) and the hereditary inclusion-
body myopathies (h-IBMs) are severe and progressive muscle diseases, c
haracterized pathologically by vacuolated muscle fibers containing pai
red-helical filaments (PHFs). An interesting feature of the s- and h-I
BM muscle phenotype is its striking similarity to Alzheimer-disease (A
D) brain. We immunostained muscle biopsies of 9 s-IBM patients, 9 auto
somal-recessive h-IBM patients, 1 autosomal-dominant h-IBM patient, an
d 18 normal and disease-controls with several antibodies known to reac
t with the hyperphosphorylated tau of AD-PHFs. Those included SMI-31,
SMI-310, PHF-1, and AT8. In both s- and h-IBM, virtually all vacuolate
d muscle fibers had strongly immunoreactive inclusions with SMI-31, an
d by immuno-electronmicroscopy SMI-31 was exclusively localized to PHF
s. Approximately 40 to 50% of both s- and h-IBM vacuolated muscle fibe
rs were also immunoreactive with AT8 antibody. To the contrary, in h-I
BM, there was no immunoreactivity with SMI-310 and PHF-1 antibodies, w
hereas in s-IBM the vacuolated muscle fibers had strong immunoreactivi
ty with those two antibodies. By immunoelectronmicroscopy, SMI-310 and
PHF-1 also were localized to PHFs. Within s-IBM muscle fibers, the st
ructures immunoreactive with SMI-310 were congophilic, whereas h-IBM m
uscle fibers did not have congophilia. Our studies: (a) demonstrate a
distinct difference between s-IBM and the h-IBMs in regard to the expr
ession of immunoreactive phosphorylated tau and congophilia; (b) demon
strate a new ''diagnostic duo'' combination of SMI-31 and SMI-310 anti
bodies for identifying and distinguishing s-IBM and the h-IBMs; and (c
) provide another close similarity of pathologic phenotypes between s-
IBM muscle and AD brain, suggesting that similar cellular pathogenic m
echanisms may be active in both diseases.